Novan (NOVN) Stock Rockets On Nitric Oxide Study

Novan NVAN Stock News

Novan Inc (NASDAQ: NOVN) is having a strong day int he market today, trading on gains of 43.53% thus far. However, with no press releases or SEC filings issued, many are scratching their heads trying to figure out what’s happening. Well, it all has to do with a study surrounding nitric oxide. Here’s what’s happening:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

NOVN Stock Rockets On Nitric Oxide Study

While there has been no SEC filings or press releases, the gains are far from unwarranted. First and foremost, you have to know what Novan does. The company is a developer of nitric oxide-based therapies. This is key.

The big reason for the gain is that a recent study showed that nitric oxide is show to have an inhibitory effect on some virus infections. The study showed that nitric oxide inhibits the replication cycle of the severe acute respiratory syndrome coronavirus or SARS in vitro. This is great news for NOVN.

Going further, the study found that organic nitric oxide donor, S-nitroso-N-acetylpenicillamine, significantly inhibited the replication cycle of SARS CoV. Moreover, nitric oxide inhibited viral protein and RNA synthesis.

All in all, the study found that nitric oxide is effective in killing SARS-coronavirus. This is huge news. After all, SARS-coronavirus is a cousin strain of COVID-19, the virus at the center of the epidemic today. Of course, this opens the door to the potential for NOVNN to develop a treatment with their expertise in nitric oxide.

What To Watch For Ahead

Considering that a third party found that nitric oxide is effective in fighting COVID-19, Novan has a huge opportunity to capitalize here. With this in mind, I’m expecting to see an announcement from the company surrounding their work to fight the coronavirus.

Should the company use its experience in nitric oxide to develop a for the Wuhan coronavirus, it will join the ranks of only a handful of companies that have potential treatment options in studies. Of course, a treatment that proves to be effective will be an overwhelmingly profitable venutre.

So, keep your eyes on NOVN as any news from the company surrounding work to combat COVID-19 could send the stock through the roof.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Don’t Miss The Next Big Story!

Join our free mailing list below to receive free real-time news alerts!

Subscribe Today!

* indicates required

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.